Mycovia Pharmaceuticals and Jiangsu Hengrui Medicine Announce Partnership to Develop and Commercialize VT-1161 for Recurrent Vulvovaginal Candidiasis and Other Fungal Conditions

77

DURHAM, N.C. & SHANGHAI–(BUSINESS WIRE)–Mycovia and Hengrui Medicine Partner to Develop and Commercialize VT-1161 for Recurrent Vulvovaginal Candidiasis and Other Fungal Conditions …..

 

 

 

 

 

http://www.businesswire.com/news/home/20190617005153/en/Mycovia-Pharmaceuticals-Jiangsu-Hengrui-Medicine-Announce-Partnership